Maple Tree regularly produces insights into the UK's medical cannabis industry.
Our reports, available for download, provide a comprehensive overview of market trends, legislative updates, and opportunities in this dynamic sector.
Our publications are essential for investors, policymakers, and industry stakeholders seeking in-depth knowledge and guidance. Each report includes detailed analyses and recommendations, ensuring you stay ahead in understanding and capitalising on the medical cannabis market.
For tailored insights specific to your business needs, Maple Tree also offers bespoke report services. Contact us to discuss how we can support your objectives with customised research and analysis.
UK Medical Cannabis: Five Years On
Five years ago, the UK stood at the edge of a revolutionary change in its medical and economic landscape: the legalisation of medical cannabis following a landmark legal battle.
As Maple Tree pause at this five year mark to reflect on the journey so far, we're positive about the achievements so far and cautiously optimistic about the UK’s ability to navigate the challenges that lie ahead.
Recommendations for Government
Maple Tree drafted a special discussion paper for the Government, in early 2021, outlining ten recommendations for the UK Medical Cannabis and CBD Market.
The discussion paper aims to reduce the red tape currently hampering what could be a multi-billion pound industry, transforming the lives of our patients.